Learn more about investing in Sun Genomics

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Sun Genomics
Microbiome health company curing dysbiosis through precision probiotics
Founded
2016
Employees*
11-50
Funding to Date*
$11.6M
Website
sungenomics.com
* Data source: Crunchbase
Sunny Jain, CEO
Our vast database of over 100,000 genomes allows our team of microbiome scientists to make calls related to not only bacterial strains but fungi, parasites, and viruses found in the gut microbiome, thereby allowing us to create custom probiotics for the end user.
Recent scientific research indicated that between 30 and 50% of all people with autism suffer from chronic gastrointestinal (GI) problems.

Sun Genomics is a microbiome health company focused on curing dysbiosis through personalized probiotics. Our platform enables the highest resolution profiling of customer gut makeup, empowering them to make and track changes over time.